Soleno Therapeutics, Inc. (SLNO) financial statements (2022 and earlier)

Company profile

Business Address 203 REDWOOD SHORES PARKWAY
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments21,30449,22420,73323,09917,1002,7265,495
Cash and cash equivalents21,30449,22420,73323,09917,1002,7265,495
Restricted cash and investments    353535
Receivables   64 133156
Inventory, net of allowances, customer advances and progress billings     660551
Inventory     660551
Other undisclosed current assets1,1181,0194111,507859247168
Total current assets:22,42250,24321,14424,67017,9943,8016,404
Noncurrent Assets
Finance lease, right-of-use asset 1524
Operating lease, right-of-use asset421124398
Property, plant and equipment331922122310386
Intangible assets, net (including goodwill)12,63714,58116,52518,46920,413943993
Goodwill     817917
Intangible assets, net (excluding goodwill)12,63714,58116,52518,46920,41312676
Other noncurrent assets40 59 126718718
Other undisclosed noncurrent assets    466  
Total noncurrent assets:13,13114,73917,02818,48121,0281,7641,797
TOTAL ASSETS:35,55364,98238,17243,15139,0225,5658,201
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,9824,4942,278934633538695
Accounts payable3,2543,4891,995934633538695
Employee-related liabilities7281,005283    
Debt 8322    
Derivative instruments and hedges, liabilities      865
Disposal group, including discontinued operation    127  
Other liabilities323196382    
Other undisclosed current liabilities3,7023,9201,9829439731,1691,633
Total current liabilities:8,0078,6184,9641,8771,7331,7073,193
Noncurrent Liabilities
Long-term debt and lease obligation175 147    
Finance lease, liability  8
Operating lease, liability175 139
Liabilities, other than long-term debt  1474,0629,737143109
Deferred tax liabilities, net4,0624,417  
Disposal group, including discontinued operation, liabilities    225  
Other liabilities  147 13143109
Business combination, contingent consideration, liability    5,082  
Other undisclosed noncurrent liabilities9,40310,81717,9676,7991,017280 
Total noncurrent liabilities:9,75310,81718,26110,86110,754422109
Total liabilities:17,76019,43523,22512,73812,4872,1303,302
Stockholders' equity
Stockholders' equity attributable to parent, including:17,79345,54714,94730,41326,5353,4353,224
Common stock80804532191714
Additional paid in capital231,068227,912172,708157,413140,495101,73089,456
Accumulated deficit(213,355)(182,445)(157,806)(127,032)(113,979)(98,312)(86,247)
Other undisclosed stockholders' equity attributable to parent    000
Total stockholders' equity:17,79345,54714,94730,41326,5353,4353,224
Other undisclosed liabilities and equity      1,675
TOTAL LIABILITIES AND EQUITY:35,55364,98238,17243,15139,0225,5658,201

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues  173  1,451607
Revenue, net 1,451607
Sublease income  173
Cost of revenue     (1,509)(353)
Gross profit:  173  (59)255
Operating expenses(31,528)(36,289)(23,486)(14,301)(12,171)(13,552)(12,415)
Other operating expense, net
(Other Nonrecurring (Income) Expense)
    (590)  
Other undisclosed operating income (loss)  (173) 590  
Operating loss:(31,528)(36,289)(23,486)(14,301)(12,171)(13,610)(12,160)
Nonoperating income (expense)61811,650(7,288)2,460(1,553)1,567 
Investment income, nonoperating   1,994   
Other nonoperating income (expense)11013154(62)(1,553)1,567 
Interest and debt expense (2)(1)   (3,049)
Other undisclosed income from continuing operations before equity method investments, income taxes 21 27,449  
Income (loss) from continuing operations before equity method investments, income taxes:(30,910)(24,639)(30,774)(11,841)13,724(12,044)(15,209)
Loss from equity method investments  (478)(160)   
Other undisclosed income (loss) from continuing operations before income taxes   160(27,449)  
Loss from continuing operations before income taxes:(30,910)(24,639)(31,252)(11,841)(13,724)(12,044)(15,209)
Income tax expense (benefit)    1,650(22) 
Loss from continuing operations:(30,910)(24,639)(31,252)(11,841)(12,074)(12,065)(15,209)
Loss from discontinued operations   (1,494)(3,594)  
Loss before gain (loss) on sale of properties:(30,910)(24,639)(31,252)(13,335)(15,667)(12,065)(15,209)
Other undisclosed net income  478    
Net loss:(30,910)(24,639)(30,774)(13,335)(15,667)(12,065)(15,209)
Other undisclosed net loss attributable to parent      (699)
Net loss attributable to parent:(30,910)(24,639)(30,774)(13,335)(15,667)(12,065)(15,909)
Preferred stock dividends and other adjustments     (3,651)(3,049)
Net loss available to common stockholders, diluted:(30,910)(24,639)(30,774)(13,335)(15,667)(15,716)(18,958)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(30,910)(24,639)(30,774)(13,335)(15,667)(12,065)(15,209)
Comprehensive loss, net of tax, attributable to parent:(30,910)(24,639)(30,774)(13,335)(15,667)(12,065)(15,209)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: